BR112020023429A2 - métodos e aparelhos para a previsão multimodal usando um modelo estatístico treinado - Google Patents
métodos e aparelhos para a previsão multimodal usando um modelo estatístico treinado Download PDFInfo
- Publication number
- BR112020023429A2 BR112020023429A2 BR112020023429-0A BR112020023429A BR112020023429A2 BR 112020023429 A2 BR112020023429 A2 BR 112020023429A2 BR 112020023429 A BR112020023429 A BR 112020023429A BR 112020023429 A2 BR112020023429 A2 BR 112020023429A2
- Authority
- BR
- Brazil
- Prior art keywords
- data
- modality
- encoder
- gene
- training
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 275
- 238000013179 statistical model Methods 0.000 title claims abstract description 174
- 230000003993 interaction Effects 0.000 claims abstract description 195
- 230000008569 process Effects 0.000 claims abstract description 61
- 230000008878 coupling Effects 0.000 claims abstract description 18
- 238000010168 coupling process Methods 0.000 claims abstract description 18
- 238000005859 coupling reaction Methods 0.000 claims abstract description 18
- 238000012549 training Methods 0.000 claims description 348
- 239000013598 vector Substances 0.000 claims description 313
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 290
- 201000010099 disease Diseases 0.000 claims description 286
- 229940079593 drug Drugs 0.000 claims description 267
- 239000003814 drug Substances 0.000 claims description 267
- 108090000623 proteins and genes Proteins 0.000 claims description 215
- 238000010348 incorporation Methods 0.000 claims description 97
- 210000003484 anatomy Anatomy 0.000 claims description 42
- 230000014509 gene expression Effects 0.000 claims description 26
- 238000003860 storage Methods 0.000 claims description 19
- 230000006870 function Effects 0.000 claims description 18
- 230000033228 biological regulation Effects 0.000 claims description 17
- 238000013507 mapping Methods 0.000 claims description 13
- 239000011159 matrix material Substances 0.000 claims description 12
- 238000012545 processing Methods 0.000 claims description 8
- 238000005070 sampling Methods 0.000 claims description 8
- 238000011282 treatment Methods 0.000 claims description 8
- 238000013528 artificial neural network Methods 0.000 claims description 7
- 230000008236 biological pathway Effects 0.000 claims description 7
- 238000001647 drug administration Methods 0.000 claims description 4
- 238000005516 engineering process Methods 0.000 description 14
- 210000001519 tissue Anatomy 0.000 description 12
- 230000004913 activation Effects 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 206010025323 Lymphomas Diseases 0.000 description 5
- 101150097381 Mtor gene Proteins 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 239000000090 biomarker Substances 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- 230000037361 pathway Effects 0.000 description 5
- 108010029031 Regulatory-Associated Protein of mTOR Proteins 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 239000002547 new drug Substances 0.000 description 4
- 229940124602 FDA-approved drug Drugs 0.000 description 3
- 206010064571 Gene mutation Diseases 0.000 description 3
- 102100040969 Regulatory-associated protein of mTOR Human genes 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000004850 protein–protein interaction Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 101150007337 Bcl6 gene Proteins 0.000 description 2
- 241000252212 Danio rerio Species 0.000 description 2
- 101100174573 Homo sapiens PIKFYVE gene Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 102100023085 Serine/threonine-protein kinase mTOR Human genes 0.000 description 2
- JJWKPURADFRFRB-UHFFFAOYSA-N carbonyl sulfide Chemical compound O=C=S JJWKPURADFRFRB-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000009274 differential gene expression Effects 0.000 description 2
- 239000003596 drug target Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000010801 machine learning Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000009827 uniform distribution Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 206010003571 Astrocytoma Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 241000244203 Caenorhabditis elegans Species 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 230000007067 DNA methylation Effects 0.000 description 1
- 241000255601 Drosophila melanogaster Species 0.000 description 1
- 206010013710 Drug interaction Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 208000008839 Kidney Neoplasms Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000023178 Musculoskeletal disease Diseases 0.000 description 1
- 235000017879 Nasturtium officinale Nutrition 0.000 description 1
- 240000005407 Nasturtium officinale Species 0.000 description 1
- 108700019961 Neoplasm Genes Proteins 0.000 description 1
- 102000048850 Neoplasm Genes Human genes 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 101150018494 RPTOR gene Proteins 0.000 description 1
- 108700005075 Regulator Genes Proteins 0.000 description 1
- 206010038389 Renal cancer Diseases 0.000 description 1
- 108091027967 Small hairpin RNA Proteins 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 208000026062 Tissue disease Diseases 0.000 description 1
- 208000012931 Urologic disease Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 238000004422 calculation algorithm Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000004186 co-expression Effects 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 238000013135 deep learning Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 208000005017 glioblastoma Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000010982 kidney cancer Diseases 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000002705 metabolomic analysis Methods 0.000 description 1
- 230000001431 metabolomic effect Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 230000004879 molecular function Effects 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000037425 regulation of transcription Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 239000004055 small Interfering RNA Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- 229940043263 traditional drug Drugs 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 208000014001 urinary system disease Diseases 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/70—Machine learning, data mining or chemometrics
Landscapes
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Data Mining & Analysis (AREA)
- Chemical & Material Sciences (AREA)
- Databases & Information Systems (AREA)
- Evolutionary Computation (AREA)
- Computing Systems (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Artificial Intelligence (AREA)
- Crystallography & Structural Chemistry (AREA)
- Software Systems (AREA)
- Bioethics (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physiology (AREA)
- Image Analysis (AREA)
- Complex Calculations (AREA)
- Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862678083P | 2018-05-30 | 2018-05-30 | |
| US201862678094P | 2018-05-30 | 2018-05-30 | |
| US62/678,094 | 2018-05-30 | ||
| US62/678,083 | 2018-05-30 | ||
| PCT/US2019/031260 WO2019231624A2 (en) | 2018-05-30 | 2019-05-08 | Methods and apparatus for multi-modal prediction using a trained statistical model |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112020023429A2 true BR112020023429A2 (pt) | 2021-02-23 |
Family
ID=66625356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112020023429-0A BR112020023429A2 (pt) | 2018-05-30 | 2019-05-08 | métodos e aparelhos para a previsão multimodal usando um modelo estatístico treinado |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP3803884A2 (https=) |
| JP (1) | JP7490576B2 (https=) |
| KR (1) | KR20210018333A (https=) |
| CN (1) | CN112513990A (https=) |
| AU (1) | AU2019276730A1 (https=) |
| BR (1) | BR112020023429A2 (https=) |
| CA (1) | CA3100065A1 (https=) |
| MX (1) | MX2020012899A (https=) |
| WO (1) | WO2019231624A2 (https=) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201904887D0 (en) * | 2019-04-05 | 2019-05-22 | Lifebit Biotech Ltd | Lifebit al |
| JP7332238B2 (ja) * | 2020-03-10 | 2023-08-23 | エスアールアイ インターナショナル | タスク固有のデータ利用のための物理学により誘導されたディープマルチモーダル埋め込みのための方法及び装置 |
| CN111540405B (zh) * | 2020-04-29 | 2023-07-07 | 新疆大学 | 一种基于快速网络嵌入的疾病基因预测方法 |
| CN111627515B (zh) * | 2020-05-29 | 2023-07-18 | 上海商汤智能科技有限公司 | 药物推荐方法、装置、电子设备及介质 |
| WO2022006676A1 (en) * | 2020-07-09 | 2022-01-13 | Mcmaster University | Machine learning prediction of biological effect in multicellular animals from microorganism transcriptional fingerprint patterns in non-inhibitory chemical challenge |
| CN111950295A (zh) * | 2020-08-10 | 2020-11-17 | 北京嘀嘀无限科技发展有限公司 | 一种训练自然语言处理模型的方法和系统 |
| CN112151127A (zh) * | 2020-09-04 | 2020-12-29 | 牛张明 | 基于分子语义向量的无监督学习药物虚拟筛选方法和系统 |
| KR20230137869A (ko) * | 2020-09-25 | 2023-10-05 | 리누스 헬스 인코포레이티드 | 기계 학습 보조 인지 평가 및 치료를 위한 시스템들 및 방법들 |
| US11756572B2 (en) | 2020-12-02 | 2023-09-12 | Google Llc | Self-supervised speech representations for fake audio detection |
| CN112700277B (zh) * | 2020-12-30 | 2024-05-28 | 北京爱笔科技有限公司 | 用户行为数据的处理方法和多行为序列转化模型训练方法 |
| US12579111B2 (en) * | 2020-12-31 | 2026-03-17 | International Business Machines Corporation | Cross-domain structural mapping in machine learning processing |
| CN112862727B (zh) * | 2021-03-16 | 2023-06-23 | 上海壁仞智能科技有限公司 | 一种跨模态图像转换方法及装置 |
| CN113223655B (zh) * | 2021-05-07 | 2023-05-12 | 西安电子科技大学 | 基于变分自编码器的药物-疾病关联预测方法 |
| JP7674636B2 (ja) * | 2021-09-27 | 2025-05-12 | オムロン株式会社 | モデル生成方法、データ提示方法、データ生成方法、推定方法、モデル生成装置、データ提示装置、データ生成装置、及び推定装置 |
| CN113869417B (zh) * | 2021-09-28 | 2025-11-14 | 清华大学 | 基于自监督和多模态的基因数据模型训练方法及装置 |
| CN113987345A (zh) * | 2021-10-27 | 2022-01-28 | 北京百度网讯科技有限公司 | 数据处理的方法、装置、设备、存储介质及程序产品 |
| CN114049930B (zh) * | 2021-11-12 | 2024-07-16 | 东南大学 | 一种基于异质网络表示学习的中药药方重定位方法 |
| CN114429787B (zh) * | 2021-12-30 | 2023-04-18 | 北京百度网讯科技有限公司 | 组学数据处理方法、装置、电子设备和存储介质 |
| CN114334038B (zh) * | 2021-12-31 | 2024-05-14 | 杭州师范大学 | 一种基于异质网络嵌入模型的疾病药物预测方法 |
| CN114613450B (zh) * | 2022-03-09 | 2025-09-19 | 平安科技（深圳）有限公司 | 药物分子的性质预测方法、装置、存储介质及计算机设备 |
| CN114626480B (zh) * | 2022-03-22 | 2024-12-13 | 国网智能电网研究院有限公司 | 多源异构数据特征提取装置、方法、存储介质及电子设备 |
| WO2023193935A1 (en) * | 2022-04-08 | 2023-10-12 | NEC Laboratories Europe GmbH | Method and system for predicting gene expression perturbations |
| KR102841093B1 (ko) * | 2022-04-18 | 2025-07-31 | 한양대학교 산학협력단 | 모달리티의 고유 특성을 보존하는 멀티미디어 추천 방법 및 시스템 |
| CN114792573B (zh) * | 2022-04-18 | 2023-02-28 | 北京百度网讯科技有限公司 | 药物联用的效果预测方法、模型训练方法、装置及设备 |
| CN118158425A (zh) * | 2022-11-30 | 2024-06-07 | 华为技术有限公司 | 图像压缩系统、图像处理方法和编解码方法及电子设备 |
| CN115587257B (zh) * | 2022-12-13 | 2023-04-07 | 阿里巴巴（中国）有限公司 | 模型超参数优化方法、存储介质和电子设备 |
| KR20240108318A (ko) * | 2022-12-30 | 2024-07-09 | 건국대학교 글로컬산학협력단 | 머신 러닝 기반 메타 분석을 이용하여 계산된 일치된 가중치 연결 점수의 앙상블에 의한 신약 재창출 후보군 예측 방법 및 장치 |
| CN116524997B (zh) * | 2023-05-04 | 2024-07-16 | 电子科技大学 | 基于经典-量子混合神经网络实现药物相互作用结果的预测系统 |
| CN116244484B (zh) * | 2023-05-11 | 2023-08-08 | 山东大学 | 一种面向不平衡数据的联邦跨模态检索方法及系统 |
| WO2024263011A1 (ko) * | 2023-06-23 | 2024-12-26 | 주식회사 엘지 경영개발원 | 멀티태스킹 모델 학습 방법 및 이를 기초로 학습된 머신러닝 모델을 이용한 멀티태스킹 수행 방법 |
| WO2025015037A1 (en) * | 2023-07-10 | 2025-01-16 | Symphony Diagnostics, Inc. | Systems and methods for animal health assessment, surveillance, and enhancement |
| CN117133436A (zh) * | 2023-10-17 | 2023-11-28 | 哈尔滨工业大学(深圳)(哈尔滨工业大学深圳科技创新研究院) | 基于多源数据融合的药物疾病关联预测方法、装置及设备 |
| WO2025105524A1 (ko) * | 2023-11-15 | 2025-05-22 | 엘지전자 주식회사 | 인공 지능 서버 및 그의 동작 방법 |
| CN118352085B (zh) * | 2024-06-14 | 2024-09-17 | 之江实验室 | 基于多时间点多模态脑影像数据的脑疾病病程预测系统 |
| WO2026016189A1 (en) * | 2024-07-19 | 2026-01-22 | Antinous Technology Company Limited | Methylation transformer for cancer detection |
| WO2026076576A1 (en) * | 2024-10-08 | 2026-04-16 | Huawei Technologies Co., Ltd. | Devices and methods for in-network learning for dynamic wireless networks |
| CN119830148B (zh) * | 2024-11-14 | 2025-10-28 | 安徽理工大学 | 基于自监督空间学习的跨模态轴承故障诊断方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6202049B1 (en) | 1999-03-09 | 2001-03-13 | Matsushita Electric Industrial Co., Ltd. | Identification of unit overlap regions for concatenative speech synthesis system |
| JP5229478B2 (ja) | 2008-12-25 | 2013-07-03 | 日本電気株式会社 | 統計モデル学習装置、統計モデル学習方法、およびプログラム |
| JP2013211616A (ja) | 2012-03-30 | 2013-10-10 | Sony Corp | 端末装置、端末制御方法、プログラム、および情報処理システム |
| US20160170982A1 (en) * | 2014-12-16 | 2016-06-16 | Yahoo! Inc. | Method and System for Joint Representations of Related Concepts |
| JP2019512758A (ja) | 2016-01-15 | 2019-05-16 | 株式会社Ｐｒｅｆｅｒｒｅｄ Ｎｅｔｗｏｒｋｓ | マルチモーダル生成機械学習のためのシステムおよび方法 |
| GB201615051D0 (en) | 2016-09-05 | 2016-10-19 | Kheiron Medical Tech Ltd | Multi-modal medical image procesing |
| CN107545151B (zh) * | 2017-09-01 | 2020-10-16 | 中南大学 | 一种基于低秩矩阵填充的药物重定位方法 |
-
2019
- 2019-05-08 JP JP2020566792A patent/JP7490576B2/ja active Active
- 2019-05-08 AU AU2019276730A patent/AU2019276730A1/en not_active Abandoned
- 2019-05-08 BR BR112020023429-0A patent/BR112020023429A2/pt not_active Application Discontinuation
- 2019-05-08 MX MX2020012899A patent/MX2020012899A/es unknown
- 2019-05-08 WO PCT/US2019/031260 patent/WO2019231624A2/en not_active Ceased
- 2019-05-08 CN CN201980050949.3A patent/CN112513990A/zh active Pending
- 2019-05-08 EP EP19725548.2A patent/EP3803884A2/en not_active Withdrawn
- 2019-05-08 KR KR1020207037772A patent/KR20210018333A/ko not_active Ceased
- 2019-05-08 CA CA3100065A patent/CA3100065A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3100065A1 (en) | 2019-12-05 |
| EP3803884A2 (en) | 2021-04-14 |
| WO2019231624A3 (en) | 2020-03-19 |
| AU2019276730A1 (en) | 2020-12-10 |
| JP7490576B2 (ja) | 2024-05-27 |
| KR20210018333A (ko) | 2021-02-17 |
| MX2020012899A (es) | 2021-02-26 |
| JP2021526259A (ja) | 2021-09-30 |
| WO2019231624A2 (en) | 2019-12-05 |
| CN112513990A (zh) | 2021-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112020023429A2 (pt) | métodos e aparelhos para a previsão multimodal usando um modelo estatístico treinado | |
| US20240296206A1 (en) | Methods and apparatus for multi-modal prediction using a trained statistical model | |
| US20240420850A1 (en) | Methods and apparatus for making biological predictions using a trained multi-modal statistical model | |
| Blaschke et al. | Memory-assisted reinforcement learning for diverse molecular de novo design | |
| Kuchaiev et al. | Geometric de-noising of protein-protein interaction networks | |
| Zou et al. | Approaches for recognizing disease genes based on network | |
| Zabad et al. | Fast and accurate Bayesian polygenic risk modeling with variational inference | |
| US20230253076A1 (en) | Local steps in latent space and descriptors-based molecules filtering for conditional molecular generation | |
| Kroll et al. | A multimodal Transformer Network for protein-small molecule interactions enhances predictions of kinase inhibition and enzyme-substrate relationships | |
| Luo et al. | Comparative Analysis of QSAR‐based vs. Chemical Similarity Based Predictors of GPCRs Binding Affinity | |
| Zhang et al. | GCMM: graph convolution network based on multimodal attention mechanism for drug repurposing | |
| Wang et al. | Identification of human disease genes from interactome network using graphlet interaction | |
| Yadalam et al. | Variational approaches for drug-disease-gene links in periodontal inflammation | |
| Ji et al. | Identifying Potential Clinical Syndromes of Hepatocellular Carcinoma Using PSO‐Based Hierarchical Feature Selection Algorithm | |
| US20250391495A1 (en) | Deep Learning Enabled Prediction of Drug-Induced Liver Injury | |
| Luo et al. | Predicting disease‐associated genes: Computational methods, databases, and evaluations | |
| US20220384039A1 (en) | Cancer type prediction system | |
| Dong et al. | Multi-objective drug design with a scaffold-aware variational autoencoder | |
| Gonzalez-Navarro et al. | Effective classification and gene expression profiling for the facioscapulohumeral muscular dystrophy | |
| Kaminsky et al. | CFOM: lead optimization for drug discovery with limited data | |
| Ghanbarpour et al. | Seq2Mol: Automatic design of de novo molecules conditioned by the target protein sequences through deep neural networks | |
| Vinod et al. | Trainable subnetworks reveal insights into structure knowledge organization in protein language models | |
| Chandrashekar et al. | Discovering novel pharmaceutical molecules with generative adversarial networks | |
| Baruah et al. | Integrating (deep) machine learning and cheminformatics for predicting human intestinal absorption of small molecules | |
| Anjana et al. | Transformer-based models for uncovering genetic mutations in cancerous and non-cancerous genomes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |